: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Arsanis(ASNS)$ 8-K - Current report Filed: 2019-03-01 AccNo: 0001193125-19-061101 Size: 48 KBItem 1.02: Termination of a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis(ASNS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-03-01 AccNo: 0001193125-19-061118 Size: 35 KB 网页链接
$Arsanis(ASNS)$ EFFECT - Notice of Effectiveness Filed: 2019-02-19 AccNo: 9999999995-19-000298 Size: 1 KB 网页链接
$Arsanis(ASNS)$ EFFECT - Notice of Effectiveness Filed: 2019-02-14 AccNo: 9999999995-19-000261 Size: 1 KB 网页链接
$Arsanis(ASNS)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-02-14 AccNo: 0001193125-19-041008 Size: 7 MB 网页链接
$Arsanis(ASNS)$ S-4/A [Amend] - Registration of securities, business combinations Filed: 2019-02-13 AccNo: 0001193125-19-038139 Size: 8 MB 网页链接
$Arsanis(ASNS)$ 8-K - Current report Filed: 2019-02-08 AccNo: 0001193125-19-032284 Size: 18 KBItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 网页链接
$Arsanis(ASNS)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-01-25 AccNo: 0001193125-19-017208 Size: 1 MB 网页链接
$Arsanis(ASNS)$ 8-K - Current report Filed: 2019-01-16 AccNo: 0001193125-19-010661 Size: 14 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Arsanis(ASNS)$ 425 - Prospectuses and communications, business combinations Filed: 2018-12-20 AccNo: 0001193125-18-354678 Size: 49 KB 网页链接